AstraZeneca licenses another Ionis antisense drug for $330 million, MiMedx shares tumble on investigation, ICER analysis of CAR-T drug costs, and more
Embed from Getty ImagesFor banking news and anonymous forums, be sure to check out cafebanking.com
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,